Enveda Biosciences is a biotechnology startup that operates in the pharmaceutical industry, specifically in the field of drug discovery. The company's primary focus is on exploring the vast, largely uncharted chemical space of the natural world to discover new medicines. Currently, only 5% of the natural world's chemical composition is known to science, and it is from this small percentage that half of all small molecule medicines are derived. Enveda aims to expand this knowledge base and accelerate the pace of drug discovery by leveraging advanced technologies such as machine learning, metabolomics, and robotics.

Enveda's business model revolves around its proprietary platform that enables high-throughput experiments, which means they can conduct a large number of tests quickly. This platform allows the company to create a comprehensive dataset of small molecules, which are tiny compounds often used in medications. By analyzing the chemical structure, biological activity, and organ distribution of these molecules, Enveda can rapidly identify potential leads for new drugs.

The company's clients are primarily in the healthcare and pharmaceutical sectors, which are always in need of new and effective treatments for various diseases. By partnering with Enveda, these entities gain access to a pipeline of potential new drugs derived from the untapped chemical resources of the natural world.

In terms of revenue generation, Enveda likely makes money through partnerships and collaborations with other companies in the pharmaceutical industry, as well as through potential licensing deals for its drug discoveries.

Keywords: Biotechnology, Drug Discovery, Natural World, Chemical Space, Machine Learning, Metabolomics, Robotics, High-Throughput Experiments, Small Molecules, Pharmaceutical Industry.